Journal of Cancer Therapy

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org
"Is the CD4/CD8 Ratio an Effective Indicator for Clinical Estimation of Adoptive Immunotherapy for Cancer Treatment?"
written by Goki Shindo, Takayoshi Endo, Masamitsu Onda, Shigenori Goto, Yoju Miyamoto, Toru Kaneko,
published by Journal of Cancer Therapy, Vol.4 No.8, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Perinatal exposure to HIV infection: the experience of Craiova Regional Centre, Romania
Healthcare, 2022
[2] Immune checkpoint proteins (PD-L1 and CTLA-4) in endometrial carcinoma: prognostic role and correlation with CD4+/CD8+ tumor infiltrating lymphocytes (TILs) …
Desouky… - … of Immunoassay and …, 2022
[3] Natural blood plasma-based hydrogels as tumor vaccines delivery systems to enhance biomimetic recruitment of antigen presenting cells for tumor …
Materials Today Bio, 2022
[4] A Clonal, Transcriptomic, and Functional Analysis of T-Cells Mobilized to Blood in Response to Acute Exercise
2022
[5] Photosensitizer-induced HPV16 E7 nanovaccines for cervical cancer immunotherapy
Biomaterials, 2022
[6] Immunophenotype rearrangement in response to tumor excision may be related to the risk of biochemical recurrence in prostate cancer patients
Journal of Clinical …, 2021
[7] The Profile and Role of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: An Immunohistochemical Study
2021
[8] Cytotoxic T cells response with decreased CD4/CD8 ratio during mammary tumors inhibition in rats induced by non-contact electric fields
2021
[9] A first‐in‐class, first‐in‐human, phase I trial of CIGB‐552, a synthetic peptide targeting COMMD1 to inhibit the oncogenic activity of NF‐κB in patients with advanced …
2021
[10] Oncolytic virotherapy: Challenges and solutions
2020
[11] Synthesis of Poly (acyclic orthoester) s: Acid‐Sensitive Biomaterials for Enhancing Immune Responses of Protein Vaccine
2020
[12] A biomimetic antitumor nanovaccine based on biocompatible calcium pyrophosphate and tumor cell membrane antigens
2020
[13] Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters
Gene therapy, 2018
[14] “Minimalist” Nanovaccine Constituted from Near Whole Antigen for Cancer Immunotherapy
ACS Nano, 2018
[15] Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion protein
2018
[16] Central JSM Clinical Oncology and Research
2017
[17] Exploring the Concept of Radiation “Booster Shot” in Combination with an Anti-PD-L1 mAb to Enhance Anti-Tumor Immune Effects in Mouse Pancreas …
Journal of clinical oncology and research, 2017
[18] Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular …
Cancer Immunology, Immunotherapy, 2017
[19] Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular …
Cancer Immunology, Immunotherapy, 2016
[20] 157 例前列腺癌患者细胞免疫功能的变化及意义
中国热带医学, 2015
[21] 河北省 2009~ 2014 年归国人员疟疾实验室检测分析
中国热带医学, 2015
[22] A complementary method to CD4 counting: measurement of CD4+/CD8+ T lymphocyte ratio in a tandem affinity microfluidic system
Biomedical microdevices, 2015
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top